Stock Taper

FRAZIER LIFE SCIENCES MANAGEMENT, L.P.

Latest 13F filing data - Q2 2026

Holdings

(Top positions)
STOCKTICKERSHARES HELD VALUE
Erasca, Inc.ERAS24.98M$457.55M
Allogene Therapeutics, Inc.ALLO22.45M$46.69M
NewAmsterdam Pharma Company N.V.NAMS18.09M$613.03M
Phathom Pharmaceuticals, Inc.PHAT12.47M$135.26M
Trevi Therapeutics, Inc.TRVI9.94M$185.37M
Arcutis Biotherapeutics, Inc.ARQT9.87M$258.91M
Mirum Pharmaceuticals, Inc.MIRM7.68M$899.06M
Aura Biosciences, Inc.AURA7.1M$50.41M
MannKind CorporationMNKD6.6M$28.12M
Aclaris Therapeutics, Inc.ACRS4.93M$26.06M
BioCryst Pharmaceuticals, Inc.BCRX4.01M$40.09M
Dyne Therapeutics, Inc.DYN3.15M$70.03M
Evolus, Inc.EOLS2.63M$18.26M
Applied Aerospace & Defense, Inc.AADX1.92M$52.57M
Design Therapeutics, Inc.DSGN1.81M$26.19M
BridgeBio Pharma, Inc.BBIO1.55M$115.31M
ACADIA Pharmaceuticals Inc.ACAD1.44M$36.39M
Disc Medicine, Inc.IRON1.35M$99.09M
Cytokinetics, IncorporatedCYTK1.16M$98.81M
Kailera Therapeutics, Inc.KLRA1.1M$24.23M